BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 16204373)

  • 1. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3'-kinase-dependent pathway.
    Lin CY; Gurlo T; Haataja L; Hsueh WA; Butler PC
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6678-86. PubMed ID: 16204373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4 increases islet amyloid deposition but offsets the resultant beta cell toxicity in human islet amyloid polypeptide transgenic mouse islets.
    Aston-Mourney K; Hull RL; Zraika S; Udayasankar J; Subramanian SL; Kahn SE
    Diabetologia; 2011 Jul; 54(7):1756-65. PubMed ID: 21484213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS; Lin TN; Wu KK
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosiglitazone, a PPARγ agonist, ameliorates palmitate-induced insulin resistance and apoptosis in skeletal muscle cells.
    Meshkani R; Sadeghi A; Taheripak G; Zarghooni M; Gerayesh-Nejad S; Bakhtiyari S
    Cell Biochem Funct; 2014 Dec; 32(8):683-91. PubMed ID: 25431031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-cell selective K(ATP)-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity.
    Ritzel RA; Jayasinghe S; Hansen JB; Sturis J; Langen R; Butler PC
    Regul Pept; 2010 Dec; 165(2-3):158-62. PubMed ID: 20619299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication increases beta-cell vulnerability to human islet amyloid polypeptide-induced apoptosis.
    Ritzel RA; Butler PC
    Diabetes; 2003 Jul; 52(7):1701-8. PubMed ID: 12829636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis.
    Fan R; Li X; Gu X; Chan JC; Xu G
    Diabetes Obes Metab; 2010 Sep; 12(9):815-24. PubMed ID: 20649634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet amyloid polypeptide exerts a novel autocrine action in β-cell signaling and proliferation.
    Visa M; Alcarraz-Vizán G; Montane J; Cadavez L; Castaño C; Villanueva-Peñacarrillo ML; Servitja JM; Novials A
    FASEB J; 2015 Jul; 29(7):2970-9. PubMed ID: 25808537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced beta-cell apoptosis in h-IAPP transgenic mice.
    Lin CY; Gurlo T; Kayed R; Butler AE; Haataja L; Glabe CG; Butler PC
    Diabetes; 2007 May; 56(5):1324-32. PubMed ID: 17353506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of peroxisome proliferator-activated receptor-gamma protects pancreatic beta-cells from cytokine-induced cytotoxicity via NF kappaB pathway.
    Kim EK; Kwon KB; Koo BS; Han MJ; Song MY; Song EK; Han MK; Park JW; Ryu DG; Park BH
    Int J Biochem Cell Biol; 2007; 39(6):1260-75. PubMed ID: 17521952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
    Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
    Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human islet amyloid polypeptide oligomers disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets.
    Ritzel RA; Meier JJ; Lin CY; Veldhuis JD; Butler PC
    Diabetes; 2007 Jan; 56(1):65-71. PubMed ID: 17192466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual role of interleukin-1β in islet amyloid formation and its β-cell toxicity: Implications for type 2 diabetes and islet transplantation.
    Park YJ; Warnock GL; Ao Z; Safikhan N; Meloche M; Asadi A; Kieffer TJ; Marzban L
    Diabetes Obes Metab; 2017 May; 19(5):682-694. PubMed ID: 28058779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and functional activity of PPARgamma in pancreatic beta cells.
    Welters HJ; McBain SC; Tadayyon M; Scarpello JH; Smith SA; Morgan NG
    Br J Pharmacol; 2004 Aug; 142(7):1162-70. PubMed ID: 15237101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone reverses insulin secretion altered by chronic exposure to free fatty acid via IRS-2-associated phosphatidylinositol 3-kinase pathway.
    Yang L; An HX; Deng XL; Chen LL; Li ZY
    Acta Pharmacol Sin; 2003 May; 24(5):429-34. PubMed ID: 12740178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.
    Lupi R; Del Guerra S; Marselli L; Bugliani M; Boggi U; Mosca F; Marchetti P; Del Prato S
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E560-7. PubMed ID: 14625208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells.
    Oskarsson ME; Hermansson E; Wang Y; Welsh N; Presto J; Johansson J; Westermark GT
    Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2752-E2761. PubMed ID: 29507232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J; Morales M; Caelles C
    Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide.
    Hull RL; Shen ZP; Watts MR; Kodama K; Carr DB; Utzschneider KM; Zraika S; Wang F; Kahn SE
    Diabetes; 2005 Jul; 54(7):2235-44. PubMed ID: 15983227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo.
    Mo XD; Gao LP; Wang QJ; Yin J; Jing YH
    Lipids Health Dis; 2018 Mar; 17(1):42. PubMed ID: 29523142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.